BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Hematology

The World Journal of Hematology (WJH) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of hematology.  It was launched on June 6, 2012 and is published trimonthly (4 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage hematologists worldwide to submit manuscripts to the WJH describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJH are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJH’s acceptance rate: 44%. Submit here >>

2017 Published Issues
3 2 1
  • Xiaoyan Jiang, MD, PhD, Associate Professor, Senior Scientist, (E-mail:xjiang@bccrc.ca)Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver V5Z 1L3, Canada
  • Thomas J Kipps, MD, PhD, Professor, (E-mail:tkipps@ucsd.edu)Department of Medicine, University of California, San Diego, Moores Cancer Center, La Jolla, CA 92093-0820, United States
China National Knowledge Infrastructure (CNKI).
Journal Metrics
There is currently no impact factor.
2218-6204 (online)
Aspirin cures erythromelalgia and cerebrovascular disturbances in JAK2-thrombocythemia through platelet-cycloxygenase inhibition 
Jan Jacques Michiels 
World J Hematol 6(3):32-54. Published online Aug 6, 2017. doi: 10.5315/wjh.v6.i3.32
Oxidative alterations in sickle cell disease: Possible involvement in disease pathogenesis 
Yesim Oztas, Ahmet Yalcinkaya 
World J Hematol 6(3):55-61. Published online Aug 6, 2017. doi: 10.5315/wjh.v6.i3.55